• <track id="lwha4"><div id="lwha4"></div></track>
    <option id="lwha4"></option>
    1.  
      Country websites:

      Our history

      1462

      Foundation of the Hirsch Pharmacy in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century.

      1912

      Dr. Eduard Fresenius, pharmacist and proprietor of the Hirsch Pharmacy commences the production of pharmaceuticals.

      1934

      The Production unit separated from the Hirsch Pharmacy and relocated to nearby Bad Homburg.

      1952

      Else Fernau, later Else Kr?ner, takes over the responsibility for the pharmacy and company after she has obtained her degree in pharmacy studies.

      1966

      Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares.

      1974

      Fresenius starts to manufacture infusion solutions and medical disposables in St. Wendel, Germany. Today, Fresenius Medical Care produces highly innovative Polysulfone dialyzers in St. Wendel.

      1979

      In a newly acquired factory in Schweinfurt, Germany, the production of the A2008 dialysis machine begins. The new machine was very successful, and awarded a gold medal for technological innovation at the Leipzig Trade Fair.

      1981

      The first peritoneal dialysis solution bags were manufactured in St. Wendel, when the system consisted of only one bag including the so-called Safe●Lock? connector that gave the Safe●Lock? standard system its name.

      1983

      The Company takes up the production of synthetic polysulfone fiber membranes for blood purification. These membranes today set the quality standards for dialyzers.

      1992

      PD Plus, an automated PD therapy option offers a mid-day exchange to enhance the therapy delivered to peritoneal dialysis patients without the need for additional supplies.

      1995/96

      Biofine? is a PVC-free material which has been developed in St. Wendel. Being free from plasticizers it provides advantages for patients and the environment. Biofine? is thinner than comparable PVC foil and cheaper to produce.

      1996

      Fresenius Medical Care is founded from a merger of Fresenius Worldwide Dialysis and National Medical Care. Fresenius Medical Care’s shares are listed at the stock exchanges in Frankfurt and New York.

      1999

      At Fresenius Medical Care the 100,000th dialysis machine comes off the production line. Fresenius Medical Cares’ ordinary share is admitted to the DAX, Germany’s blue-chip share index.

      2003

      Fresenius Medical Care is the leading dialysis company caring for more than 119,000 patients in own dialysis centers worldwide. With a production output of more than 50 million dialyzers per year Fresenius Medical Care sets a new record.

      2005

      The new dialysis therapy system 5008 is introduced in the market and wins the “Innovationspreis der Deutschen Wirtschaft” prize for this innovative development.

      2006

      Fresenius Medical Care acquired the U.S. dialysis care provider Renal Care Group, Inc. Through its network of around 2.000 dialysis clinics around the world the company provides dialysis treatments to approximately 157,000 patients.
      Fresenius Medical Care also transforms its legal form into KGaA.

      2007

      Fresenius Medical Care continues its success as the leading manufacturer of dialyzers, producing its 500,000,000th dialyzer.

      2010

      Foundation of a joint venture to develop and sell drugs for patients with chronic kidney disease.

      2011

      The worldwide expansion of the service business continues by acquiring IDC, Liberty Dialysis Holdings Inc. and American Access Care.

      2012

      Fresenius Medical Care produces the 500,000th dialysis machine.

      2013

      Fresenius Medical Care produces the 1,000,000,000th dialyzer.

      2014

      A new generation of home dialysis cyclers is launched – sleep?safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy. Compared with conventional APD, by targeting ultrafiltration and clearance separately, aAPD increases dialysis efficiency with a reduction in glucose absorption.

      2016

      Fresenius Medical Care launches 6008 CAREsystem, a new hemodialysis therapy system.

      2018

      Fresenius Medical Care launches 4008A dialysis machine tailored to needs in emerging markets.

      2019

      By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home dialysis offering patients greater flexibility and more individual treatment.
      Contact us for further information

      Related content

      6080新觉伦